Fulcrum Therapeutics FULC
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 11.31 | 111.60 | -0.31 | -22,693 | -20 | |
| 2025Q3 | 9.20 | 111.55 | -0.31 | -21,858 | -20 | |
| 2025Q2 | 6.88 | 114.56 | -0.28 | -19,815 | -17 | |
| 2025Q1 | 2.88 | 115.56 | -0.28 | -20,403 | -18 | |
| 2024Q4 | 4.70 | 117.27 | -0.27 | -19,429 | -17 | |
| 2024Q3 | 3.57 | 115.81 | -0.34 | -25,126 | -22 | |
| 2024Q2 | 6.20 | 94.74 | 0.88 | 52,492 | 55 | |
| 2024Q1 | 9.44 | 111.03 | -0.43 | -29,834 | -27 | |
| 2023Q4 | 6.75 | 113.07 | -0.40 | -27,992 | -25 | |
| 2023Q3 | 4.44 | 114.25 | -0.39 | -27,440 | -24 | |
| 2023Q2 | 3.30 | 114.75 | -0.39 | -27,292 | -24 | |
| 2023Q1 | 2.85 | 112.76 | -0.41 | -27,940 | -25 | |
| 2022Q4 | 7.28 | 107.03 | -0.47 | -27,973 | -26 | |
| 2022Q3 | 8.09 | 102.60 | -0.50 | -24,355 | -24 | |
| 2022Q2 | 4.90 | 100.48 | -0.83 | -34,235 | -34 | |
| 2022Q1 | 23.65 | 100.27 | -0.64 | -25,998 | -26 | |
| 2021Q4 | 17.69 | 100.32 | -0.58 | -23,559 | -23 | |
| 2021Q3 | 28.21 | 100.26 | -0.57 | -20,770 | -21 | |
| 2021Q2 | 10.48 | 100.17 | -0.60 | -19,682 | -20 | |
| 2021Q1 | 11.78 | 100.26 | -0.54 | -17,043 | -17 |